Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | RXRA | P19793 | 1/20 | 0.50 |
| ▸ | RXRB | P28702 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | PLK1 | P53350 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.44 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7061682 | 0.92 | RAB9A (0.54) | RAB9AALDH1A1SMN1; SMN2CYP2C19RXRA | |
| SCHEMBL7064280 | 0.90 | RAB9A (0.49) | RAB9AALDH1A1SMN1; SMN2CYP2C19RXRA | |
| SCHEMBL9577400 | 0.90 | RAB9A (0.51) | RAB9AALDH1A1SMN1; SMN2CYP2C19RXRA | |
| SCHEMBL47952 | 0.86 | RAB9A (0.56) | RAB9AALDH1A1SMN1; SMN2CYP2C19RXRA | |
| SCHEMBL4594651 | 0.86 | ELANE (0.56) | RAB9AALDH1A1SMN1; SMN2CYP2C19RXRA | |
| SCHEMBL28097757 | 0.85 | RAB9A (0.47) | RAB9AALDH1A1SMN1; SMN2CYP2C19RXRA | |
| SCHEMBL68678 | 0.84 | LMNA (0.59) | RAB9AALDH1A1SMN1; SMN2CYP2C19RXRA | |
| SCHEMBL10653416 | 0.84 | RAB9A (0.54) | RAB9AALDH1A1SMN1; SMN2CYP2C19RXRA | |
| SCHEMBL9671534 | 0.84 | RAB9A (0.54) | RAB9AALDH1A1SMN1; SMN2CYP2C19RXRA | |
| SCHEMBL9671537 | 0.84 | RAB9A (0.59) | RAB9AALDH1A1SMN1; SMN2CYP2C19RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9174918-B2 | Process for preparing diaryl oxalate | UBE INDUSTRIES, LTD. (JP) | 2015-11-03 | — | — | US | disclosed |
| US-20120296063-A1 | PROCESS FOR PREPARING DIARYL OXALATE | UBE CORPORATION (JP) | 2012-11-22 | — | — | US | disclosed |
| EP-1013633-B1 | Process for producing a diaryl carbonate | UBE INDUSTRIES (JP) | 2003-05-28 | — | — | EP | disclosed |
| EP-0795539-B1 | Process for producing a diaryl carbonate | UBE INDUSTRIES (JP) | 2001-10-31 | — | — | EP | disclosed |
| EP-0814074-B1 | PROCESS FOR PREPARING DIARYL ESTERS OF OXALIC ACID | UBE INDUSTRIES (JP) | 2001-03-28 | — | — | EP | disclosed |
| EP-1013633-A1 | Process for producing a diaryl carbonate | Ube Industries, Ltd. (JP) | 2000-06-28 | — | — | EP | disclosed |
| US-6018072-A | SUBJECTING AN ALKYLARYL OXALATE TO A DISPROPORTIONATION REACTION IN THE PRESENCE OF A DISPROPORTIONATION CATALYST TO PRODUCE A DIARYL OXALATE WHILE REMOVING A DIALKYL OXALATE BY-PRODUCT | UBE INDUSTRIES, LTD. (JP) | 2000-01-25 | — | — | US | disclosed |
| US-5811573-A | Process for producing a diaryl carnonate | UBE INDUSTRIES, LTD. (JP) | 1998-09-22 | — | — | US | disclosed |
| US-5731453-A | Process for producing a diaryl carbonate | UBE INDUSTRIES, LTD. (JP) | 1998-03-24 | — | — | US | disclosed |
| EP-0814074-A1 | PROCESS FOR PREPARING DIARYL ESTERS OF OXALIC ACID | UBE INDUSTRIES, LTD. (JP) | 1997-12-29 | — | — | EP | disclosed |
| EP-0795539-A1 | Process for producing a diaryl carbonate | UBE INDUSTRIES LIMITED (JP) | 1997-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120296063-A1 | PROCESS FOR PREPARING DIARYL OXALATE | TH, CYP2E1, ADH1A | RAB9A 3449/4885ALDH1A1 279/4885SMN1; SMN2 4750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.